May 8, 2008 / 11:21 AM / in 9 years

Labopharm's first-quarter loss deepens

TORONTO, May 8 (Reuters) - Labopharm Inc DDS.TO said on Thursday that its first-quarter loss deepened as revenue fell.

The small biotechnology company said it lost C$9.7 million, or 17 Canadian cents a share, for the quarter, compared with a loss of C$6.5 million, or 11 Canadian cents a share, a year earlier. ($1=$1.00 Canadian) (Reporting by Scott Anderson; Editing by Steve Orlofsky)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below